PetMed Enterprise Value Over E B I T D A from 2010 to 2024

PETS Stock  USD 4.05  0.06  1.46%   
PetMed Express Enterprise Value Over EBITDA yearly trend continues to be comparatively stable with very little volatility. Enterprise Value Over EBITDA is likely to outpace its year average in 2024. From the period from 2010 to 2024, PetMed Express Enterprise Value Over EBITDA quarterly data regression had mean square error of  670.72 and mean deviation of  29.45. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
95.78
Current Value
100.56
Quarterly Volatility
38.68393279
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check PetMed Express financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PetMed main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.3 M, Interest Expense of 3.6 M or Selling General Administrative of 59.7 M, as well as many exotic indicators such as Price To Sales Ratio of 1.3, Dividend Yield of 0.0362 or PTB Ratio of 2.91. PetMed financial statements analysis is a perfect complement when working with PetMed Express Valuation or Volatility modules.
  
This module can also supplement PetMed Express' financial leverage analysis and stock options assessment as well as various PetMed Express Technical models . Check out the analysis of PetMed Express Correlation against competitors.
For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.

Latest PetMed Express' Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of PetMed Express over the last few years. It is PetMed Express' Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PetMed Express' overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Slightly volatile
   Enterprise Value Over E B I T D A   
       Timeline  

PetMed Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean27.28
Coefficient Of Variation141.79
Mean Deviation29.45
Median9.71
Standard Deviation38.68
Sample Variance1,496
Range118
R-Value0.76
Mean Square Error670.72
R-Squared0.58
Significance0.0009
Slope6.61
Total Sum of Squares20,950

PetMed Enterprise Value Over E B I T D A History

2024 100.56
2023 95.78
2022 106.42
2021 14.39
2020 14.67
2019 14.23
2018 7.7

About PetMed Express Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include PetMed Express income statement, its balance sheet, and the statement of cash flows. PetMed Express investors use historical funamental indicators, such as PetMed Express's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although PetMed Express investors may use each financial statement separately, they are all related. The changes in PetMed Express's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on PetMed Express's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on PetMed Express Financial Statements. Understanding these patterns can help to make the right decision on long term investment in PetMed Express. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA 95.78  100.56 

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as PetMed Express using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether PetMed Express is a strong investment it is important to analyze PetMed Express' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PetMed Express' future performance. For an informed investment choice regarding PetMed Stock, refer to the following important reports:
Check out the analysis of PetMed Express Correlation against competitors.
For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for PetMed Stock analysis

When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Stocks Directory
Find actively traded stocks across global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Is PetMed Express' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PetMed Express. If investors know PetMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PetMed Express listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.59)
Dividend Share
0.9
Earnings Share
(0.37)
Revenue Per Share
13.599
Quarterly Revenue Growth
0.11
The market value of PetMed Express is measured differently than its book value, which is the value of PetMed that is recorded on the company's balance sheet. Investors also form their own opinion of PetMed Express' value that differs from its market value or its book value, called intrinsic value, which is PetMed Express' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PetMed Express' market value can be influenced by many factors that don't directly affect PetMed Express' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PetMed Express' value and its price as these two are different measures arrived at by different means. Investors typically determine if PetMed Express is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PetMed Express' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.